Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Breast Neoplasms 700Neoplasms 621Prostatic Neoplasms 322Lung Neoplasms 314Colorectal Neoplasms 284Carcinoma, Non-Small-Cell Lung 260Pancreatic Neoplasms 181Carcinoma, Hepatocellular 171Stomach Neoplasms 141Multiple Myeloma 127Ovarian Neoplasms 123Melanoma 118Colonic Neoplasms 114Brain Neoplasms 111Hematologic Neoplasms 107Urinary Bladder Neoplasms 104Head and Neck Neoplasms 104Leukemia, Myeloid, Acute 102Esophageal Neoplasms 100Disease 100Uterine Cervical Neoplasms 91Liver Neoplasms 91Neoplasm Metastasis 89Lymphoma 86Rectal Neoplasms 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 84Endometrial Neoplasms 79Carcinoma, Renal Cell 74Leukemia 65Recurrence 63

Interventions

Solutions 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lennox Gastaut Syndrome × 1 year × Clear all
NCT05485831 2026-06-03

EpiTALY

Jazz Pharmaceuticals

Active not recruiting
111 enrolled

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡